{"id":"https://openalex.org/W7221030979","doi":"https://doi.org/10.3389/fphar.2026.1961418","title":"Evaluation of the anticancer effects of kaempferol using in vitro assays and [99mTc]Tc-PSMA SPECT/CT imaging in a DMBA-induced breast cancer model","display_name":"Evaluation of the anticancer effects of kaempferol using in vitro assays and [99mTc]Tc-PSMA SPECT/CT imaging in a DMBA-induced breast cancer model","publication_year":2026,"publication_date":"2026-10-08","ids":{"openalex":"https://openalex.org/W7221030979","doi":"https://doi.org/10.3389/fphar.2026.1961418","pmid":"https://pubmed.ncbi.nlm.nih.gov/42922955","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13687055"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1961418","doi":"https://doi.org/10.3389/fphar.2026.1961418","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1961418","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1961418/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1961418/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069932424","display_name":"Fatma J. Al\u2010Saeedi","orcid":"https://orcid.org/0000-0003-0932-6261","observed_orcids":["https://orcid.org/0000-0003-0932-6261"]},"institutions":[{"id":"https://openalex.org/I36721946","display_name":"Kuwait University","ror":"https://ror.org/021e5j056","country_code":"KW","type":"education","lineage":["https://openalex.org/I36721946"]}],"countries":["KW"],"is_corresponding":true,"raw_author_name":"Fatma J. Al-Saeedi","raw_affiliation_strings":["Department of Nuclear Medicine, College of Medicine, Kuwait University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, College of Medicine, Kuwait University","institution_ids":["https://openalex.org/I36721946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069932424"],"corresponding_institution_ids":["https://openalex.org/I36721946"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.71560212,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1961418","last_page":"1961418"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10035","display_name":"Phytochemicals and Antioxidant Activities","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kaempferol","display_name":"kaempferol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/flavonoids","display_name":"flavonoids","score":0.8700000047683716},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/dmba-induced-mammary-tumors","display_name":"DMBA-induced mammary tumors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.8450000286102295},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9010000228881836},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6240000128746033},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.875},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cancer-cell-viability","display_name":"tumor cell viability","score":0.6079999804496765},{"id":"https://openalex.org/keywords/tumor-to-background-ratio","display_name":"tumor-to-background ratio","score":0.6909999847412109},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.5860000252723694},{"id":"https://openalex.org/keywords/rat-model","display_name":"rat model","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C2777810353","wikidata":"https://www.wikidata.org/wiki/Q393336","display_name":"Kaempferol","level":4,"score":0.8374999761581421},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7731999754905701},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.671500027179718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.553600013256073},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.545199990272522},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5198000073432922},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48579999804496765},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46889999508857727},{"id":"https://openalex.org/C2781263971","wikidata":"https://www.wikidata.org/wiki/Q409478","display_name":"Quercetin","level":3,"score":0.4458000063896179},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.43689998984336853},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.388700008392334},{"id":"https://openalex.org/C2776260442","wikidata":"https://www.wikidata.org/wiki/Q4596897","display_name":"2-Methoxyestradiol","level":3,"score":0.37770000100135803},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3612000048160553},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3424000144004822},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3246000111103058},{"id":"https://openalex.org/C2779054382","wikidata":"https://www.wikidata.org/wiki/Q72185287","display_name":"Flavonoid","level":3,"score":0.29109999537467957},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.2883000075817108},{"id":"https://openalex.org/C29331040","wikidata":"https://www.wikidata.org/wiki/Q7239554","display_name":"Preclinical imaging","level":3,"score":0.2768999934196472},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.27619999647140503},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.27459999918937683},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.26440000534057617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2612999975681305},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.26109999418258667},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.2556000053882599}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1961418","doi":"https://doi.org/10.3389/fphar.2026.1961418","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1961418","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1961418/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13687055","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13687055/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13687055/pdf/fphar-17-1961418.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42922955","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42922955","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:70e94af0a963403dbc34cce1869d43d9","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/70e94af0a963403dbc34cce1869d43d9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1961418","doi":"https://doi.org/10.3389/fphar.2026.1961418","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1961418","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1961418/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1381565724","display_name":null,"funder_award_id":"#SRUL02/13","funder_id":"https://openalex.org/F4320322668","funder_display_name":"Kuwait University"}],"funders":[{"id":"https://openalex.org/F4320322668","display_name":"Kuwait University","ror":"https://ror.org/021e5j056"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221030979.pdf","grobid_xml":"https://content.openalex.org/works/W7221030979.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W2054206661","https://openalex.org/W2102306356","https://openalex.org/W2124190794","https://openalex.org/W2177701233","https://openalex.org/W2301806565","https://openalex.org/W2556181935","https://openalex.org/W2754767694","https://openalex.org/W2757424513","https://openalex.org/W2802491306","https://openalex.org/W2916117450","https://openalex.org/W2921598575","https://openalex.org/W2951902079","https://openalex.org/W2965216369","https://openalex.org/W4212865324","https://openalex.org/W4223930506","https://openalex.org/W4310534296","https://openalex.org/W4311367289","https://openalex.org/W4311453672","https://openalex.org/W4319598530","https://openalex.org/W4362658954","https://openalex.org/W4378713826","https://openalex.org/W4379794549","https://openalex.org/W4387299010","https://openalex.org/W4391375908","https://openalex.org/W4392018709","https://openalex.org/W4395450438","https://openalex.org/W4399140264","https://openalex.org/W4400934722","https://openalex.org/W4406063397","https://openalex.org/W4408226507","https://openalex.org/W4408236237","https://openalex.org/W4408536821","https://openalex.org/W4410154744","https://openalex.org/W4412112668","https://openalex.org/W4413024617","https://openalex.org/W4414516410","https://openalex.org/W4414677028","https://openalex.org/W4414926252","https://openalex.org/W4416413273","https://openalex.org/W4417435923","https://openalex.org/W7119508092","https://openalex.org/W7125823754","https://openalex.org/W7140509093","https://openalex.org/W7151933336","https://openalex.org/W7154449045","https://openalex.org/W7163155662"],"related_works":["https://openalex.org/W2513664671","https://openalex.org/W2802491306","https://openalex.org/W2341062931","https://openalex.org/W1787043696","https://openalex.org/W4393074408","https://openalex.org/W2987535546","https://openalex.org/W1921220968","https://openalex.org/W2794871025","https://openalex.org/W4361288106","https://openalex.org/W3030154449"],"abstract_inverted_index":{"Background":[0],"Kaempferol":[1,164,184,272],"is":[2],"a":[3,38,72,170,255,305],"naturally":[4],"occurring":[5],"flavonoid":[6],"with":[7,60,173,188],"reported":[8],"anticancer":[9],"properties;":[10],"however,":[11],"its":[12],"effects":[13,29,276],"on":[14],"breast":[15,42,55,289],"cancer":[16,43,56,117,228,247,290],"cells":[17,57],"and":[18,37,62,81,86,121,133,157,197,233,249,277,320],"tumor-associated":[19,293],"molecular":[20,321],"imaging":[21,156,203,322],"require":[22],"further":[23],"investigation.":[24],"This":[25],"study":[26],"evaluated":[27,150],"the":[28,68,82,143,212,227,246,287,312],"of":[30,75,84,105,180,279,315],"kaempferol":[31,119,136,302],"using":[32,67,100,131,151,159],"complementary":[33,313],"in":[34,169,207,283,316,327],"vitro":[35,317],"assays":[36,319],"7,12-dimethylbenz":[39],"[a]anthracene":[40],"(DMBA)-induced":[41],"rat":[44],"model":[45],"assessed":[46,66],"by":[47],"[":[48,152,294],"99m":[49,153,295],"Tc]Tc-PSMA":[50,154,296],"SPECT/CT":[51,155],"imaging.":[52],"Methods":[53],"MCF-7":[54,166,284],"were":[58,88,114,129],"treated":[59],"kaempferol,":[61],"cell":[63,167],"viability":[64,168],"was":[65,98,149,186,243,298],"MTT":[69],"assay":[70],"across":[71],"concentration":[73,94],"range":[74],"0\u201380":[76],"\u00b5M.":[77,183],"Apoptosis,":[78],"wound":[79,192],"closure,":[80,193],"expression":[83],"E-cadherin":[85,195],"VEGF":[87,199],"also":[89],"evaluated.":[90],"The":[91,215,309],"half-maximal":[92],"inhibitory":[93],"(IC":[95],"50":[96,179],")":[97],"estimated":[99],"nonlinear":[101,174],"four-parameter":[102],"logistic":[103],"regression":[104,175],"replicate-level":[106],"concentration\u2013response":[107],"data.":[108],"In":[109,201,286],"vivo":[110,202],",":[111],"8-week-old":[112],"rats":[113],"allocated":[115],"into":[116],"control,":[118],"pre-treatment,":[120,303],"post-treatment":[122,234,250],"groups":[123,235],"(n":[124],"=":[125,262,269],"10/group).":[126],"Mammary":[127],"tumors":[128],"induced":[130],"DMBA,":[132],"animals":[134],"received":[135],"(100":[137],"mg/kg/day,":[138],"oral":[139],"gavage)":[140],"according":[141],"to":[142,323],"experimental":[144,213],"protocol.":[145],"Tumor-associated":[146],"tracer":[147,209],"uptake":[148,210,297],"quantified":[158],"tumor-to-background":[160],"ratios":[161],"(TBRs).":[162],"Results":[163],"reduced":[165,191,292],"concentration-dependent":[171,274],"manner,":[172],"estimating":[176],"an":[177],"IC":[178],"approximately":[181],"40":[182],"treatment":[185],"associated":[187],"increased":[189,194],"apoptosis,":[190],"expression,":[196],"decreased":[198],"expression.":[200],"demonstrated":[204,254,273],"significant":[205,241,256],"differences":[206],"tumor":[208,328],"among":[211],"groups.":[214,251],"pre-treatment":[216],"group":[217,258],"showed":[218],"significantly":[219],"lower":[220],"TBR":[221],"values":[222],"(64.65":[223],"\u00b1":[224,231,237],"1.69)":[225],"than":[226],"control":[229,248],"(71.18":[230],"1.83)":[232],"(71.16":[236],"1.06),":[238],"whereas":[239],"no":[240],"difference":[242],"observed":[244,299],"between":[245],"One-way":[252],"ANOVA":[253],"overall":[257],"effect":[259],"(F":[260],"(2,27)":[261],"58.08,":[263],"p":[264],"<":[265],"0.001,":[266],"\u03b7":[267],"2":[268],"0.81).":[270],"Conclusion":[271],"cytotoxic":[275],"modulation":[278],"cancer-associated":[280],"cellular":[281],"markers":[282],"cells.":[285],"DMBA-induced":[288],"model,":[291],"predominantly":[300],"following":[301],"suggesting":[304],"potential":[306],"chemopreventive":[307],"effect.":[308],"findings":[310],"support":[311],"use":[314],"pharmacological":[318],"investigate":[324],"treatment-associated":[325],"changes":[326],"biology.":[329]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-09T00:00:00"}